ALLMedicine™ Menorrhagia Center

Feb 13th, 2021 - Adenomyosis and endometriosis are common causes of pelvic pain in women of reproductive age. Furthermore, adenomyosis is a major cause of menorrhagia. This study aimed to evaluate the effects of Etonogestrel implants on pelvic pain and menstrual f...

Feb 7th, 2021 - To explore the prognostic role of ovarian endometriosis in symptomatic adenomyosis patients underwent uterine artery embolization (UAE). This was a retrospective, single-center study. A total of 76 patients with adenomyosis who underwent UAE in Th...

Feb 2nd, 2021 - The presentation of idiopathic intracranial hypertension (IIH) in association with iron deficiency anemia (IDA) is rare. This case report depicts the unusual case of a 31-year-old woman of mixed Jamaican and English heritage with IIH who presented...

Jan 25th, 2021 - Do adenomyosis phenotypes such as external or internal adenomyosis, as diagnosed by MRI, have the same clinical characteristics? External adenomyosis was found more often in young and nulliparous women and was associated with deep infiltrating end...

Dec 14th, 2020 - To investigate whether menstrual symptoms are associated with increased risk of hypertension among young women, and whether the relationship is bi-directional. We included 7729 women participating in the Australian Longitudinal Study on Women's He...

Feb 15th, 2018 - The prevalence of bleeding disorders, notably von Willebrand disease (vWD), among adult women with objectively documented menorrhagia is consistently reported to be 10% to 20% and is even higher in adolescents presenting with menorrhagia. Diagnost...

Aug 6th, 2010 - Normal menstrual periods last 3-6 days and involve blood loss of up to 80ml. Menorrhagia is defined as menstrual periods lasting more than 7 days and/or involving blood loss greater than 80ml. The prevalence of abnormal uterine bleeding (AUB) is e...

Nov 25th, 2008 - Endometrial ablation is an effective therapeutic option for the management of menorrhagia in properly selected patients. Hysteroscopic and non-hysteroscopic techniques offer similar rates of symptom relief and patient satisfaction.

Jul 11th, 2008 - Uterine leiomyomas (fibroids), the most common benign tumor in women of childbearing age, can cause symptoms including dysmenorrhea, menorrhagia, urinary symptoms, pain and infertility. Hysterectomy is a common approach to treating uterine fibroid...

Feb 16th, 2021 - Vitrexate FE is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss and advanced age.Also for the treatment of a condition in which iron de...

Feb 13th, 2021 - Adenomyosis and endometriosis are common causes of pelvic pain in women of reproductive age. Furthermore, adenomyosis is a major cause of menorrhagia. This study aimed to evaluate the effects of Etonogestrel implants on pelvic pain and menstrual f...

Feb 10th, 2021 - Ribotin-E TM is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss, and advanced age. Also for the treatment of the condition in which iro...

Feb 10th, 2021 - Folitin-Z TM is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss, and advanced age. Also for the treatment of the condition in which iro...

Feb 10th, 2021 - Zintrexyl-C TM is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss, and advanced age. Also for the treatment of the condition in which i...

Feb 6th, 2019 - ENDOMETRIAL ABLATION TECHNOLOGY AEGEA Medical introduces the AEGEA Vapor SystemTM, an innovative solution for endometrial ablation to treat menorrhagia. The system uses Adaptive Vapor Ablation and is the first endometrial ablation system specifica.

Jun 1st, 2018 - A 50-year-old woman presents for a new patient visit. She underwent vaginal hysterectomy for menorrhagia 4 years ago, with removal of the uterus and cervix.

Feb 22nd, 2018 - Tranexamic acid is a synthetic lysine derivative that inhibits plasminogen activation by blocking lysine-binding sites on the plasminogen molecule. Although the US Food and Drug Administration–approved indications for tranexamic acid include treat.

Feb 16th, 2018 - SAN DIEGO – The use of tranexamic acid, a prothrombotic agent approved in the United States for treatment of menorrhagia, is “truly a breakthrough” in the treatment of melasma, according to Amit Pandya, MD. Tranexamic acid is also used to treat in.

Aug 3rd, 2017 - Quality of life was higher, and costs were lower, with the levonorgestrel-releasing intrauterine system for treatment of heavy menstrual bleeding than with three other common treatments, according to data from a model and a hypothetical population.